Cost, Value and Access of Personalized MedicineVideo Categories: Value
Atheer Kaddis presents the role of the pharmacist with regards to polycythemia vera and describes why it is unique.Supported through funding from Incyte
Dr. David S. Siegel discusses the importance of understanding the molecular biology of myeloma. Physicians can now look at and offer alternative treatments to patients that they identify will most likely do poorly with traditional treatment. He believes this area will develop quickly over the next 2 to 5 years.